Literature DB >> 10988265

CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension.

E Bush1, N Maeda, W A Kuziel, T C Dawson, J N Wilcox, H DeLeon, W R Taylor.   

Abstract

Recent studies have identified the presence of macrophages in the arterial wall of hypertensive animals and suggested that as is the case in atherosclerosis, macrophage products may be important mediators of the adaptive response of the arterial wall. In support of this, we have previously shown that the expression of monocyte chemoattractant protein-1 is upregulated in the arteries of hypertensive animals. We hypothesized that macrophage recruitment is a critical step in the pathogenesis of hypertension. To obtain insights into this potential mechanism, we made use of mice deficient in the CC chemokine receptor 2 (CCR2), the receptor for monocyte chemoattractant protein-1. Hypertension was induced with the subcutaneous administration of angiotensin II (0.75 mg. kg(-1). d(-1)) for 7 days. Using in situ hybridization with a probe for c-fms to identify macrophages, we found that hypertension-induced macrophage infiltration of the arterial wall was virtually eliminated in CCR2-deficient mice. In addition, vascular hypertrophy was reduced by approximately 65% compared with wild-type animals. These data demonstrate that CCR2 is essential for the recruitment of macrophages into the arterial wall in the setting of hypertension. Furthermore, the decreased hypertrophic response suggests that vascular hypertrophy occurs in part as a consequence of macrophage infiltration. In angiotensin II-induced hypertension, CCR2-mediated responses are critical to the process of macrophage recruitment and vascular hypertrophy and may represent one mechanism by which at least some forms of hypertension may lead to the development of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10988265     DOI: 10.1161/01.hyp.36.3.360

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  50 in total

1.  The adventitia: the outs and ins of vascular disease.

Authors:  Patrick J Pagano; David D Gutterman
Journal:  Cardiovasc Res       Date:  2007-07-16       Impact factor: 10.787

Review 2.  Role of immune cells in hypertension.

Authors:  Antoine Caillon; Pierre Paradis; Ernesto L Schiffrin
Journal:  Br J Pharmacol       Date:  2018-07-20       Impact factor: 8.739

3.  Ubiquitin-activating enzyme E1 inhibitor PYR41 attenuates angiotensin II-induced activation of dendritic cells via the IκBa/NF-κB and MKP1/ERK/STAT1 pathways.

Authors:  Chen Chen; Yan Meng; Lei Wang; Hong-Xia Wang; Cui Tian; Guo-Dong Pang; Hui-Hua Li; Jie Du
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

Review 4.  Macrophage heterogeneity and renin-angiotensin system disorders.

Authors:  Mark D Wright; Katrina J Binger
Journal:  Pflugers Arch       Date:  2017-02-08       Impact factor: 3.657

Review 5.  Macrophages in vascular inflammation--From atherosclerosis to vasculitis.

Authors:  Tsuyoshi Shirai; Marc Hilhorst; David G Harrison; Jörg J Goronzy; Cornelia M Weyand
Journal:  Autoimmunity       Date:  2015-03-26       Impact factor: 2.815

Review 6.  The role of chemokines in hypertension and consequent target organ damage.

Authors:  Nathan P Rudemiller; Steven D Crowley
Journal:  Pharmacol Res       Date:  2017-03-06       Impact factor: 7.658

7.  The endothelium: paracrine mediator of aortic dissection.

Authors:  Francesca Seta; Richard A Cohen
Journal:  Circulation       Date:  2014-05-07       Impact factor: 29.690

8.  NOX and inflammation in the vascular adventitia.

Authors:  Gábor Csányi; W Robert Taylor; Patrick J Pagano
Journal:  Free Radic Biol Med       Date:  2009-07-21       Impact factor: 7.376

9.  An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice.

Authors:  Brian C Tieu; Chang Lee; Hong Sun; Wanda Lejeune; Adrian Recinos; Xiaoxi Ju; Heidi Spratt; Dong-Chuan Guo; Dianna Milewicz; Ronald G Tilton; Allan R Brasier
Journal:  J Clin Invest       Date:  2009-11-16       Impact factor: 14.808

10.  Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice.

Authors:  Alan Daugherty; Debra L Rateri; Israel F Charo; A Phillip Owens; Deborah A Howatt; Lisa A Cassis
Journal:  Clin Sci (Lond)       Date:  2010-03-09       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.